课题基金 / 基金详情

FACTOR V LEIDEN PATIENTS WITH CORONARY ARTERY VEIN GRAFT OCCLUSION

FACTOR V LEIDEN PATIENTS WITH CORONARY ARTERY VEIN GRAFT OCCLUSION
冠状动脉静脉移植物闭塞的 V 因子 LEIDEN 患者
批准号：
6122745
负责人：
DAVID McLeod HERRINGTON
金额：
$3.88万
依托单位：
WAKE FOREST UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6122745
关键词：
blood vessel transplantation cardiovascular disorder epidemiology clinical research coagulation factor V gene mutation human subject medical complication transplant rejection vein occlusion venous thrombosis

项目摘要

项目成果

DAVID McLeod HERRINGTON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Based on the primary hypothesis that prevalence of the Factor V Leiden mutation will be higher in patients with vein graft occlusions than in those without, this pilot study seeks to estimate the prevalence of the mutation in 100 patients w/ 100 patients without angiographically proven vein graft occlusion. The presence of the mutation is strongly associated w/ deep venous but not arterial thrombotic events. If the association can be established with greater risk of veingraft failure, an argument could be made to avoid vein grafts in pts w/ the mutation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomic and Proteomic Architecture of Atherosclerosis
Genomic and Proteomic Architecture of Atherosclerosis
Genomic and Proteomic Architecture of Atherosclerosis
Genomic and Proteomic Architecture of Atherosclerosis